226 related articles for article (PubMed ID: 23075330)
1. Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression.
Jin Z; Zhao C; Han X; Han Y
BMC Cancer; 2012 Oct; 12():480. PubMed ID: 23075330
[TBL] [Abstract][Full Text] [Related]
2. SFRP5 inhibits gastric epithelial cell migration induced by macrophage-derived Wnt5a.
Zhao C; Ma H; Bu X; Wang W; Zhang N
Carcinogenesis; 2013 Jan; 34(1):146-52. PubMed ID: 23054609
[TBL] [Abstract][Full Text] [Related]
3. GEC-derived SFRP5 inhibits Wnt5a-induced macrophage chemotaxis and activation.
Zhao C; Bu X; Wang W; Ma T; Ma H
PLoS One; 2014; 9(1):e85058. PubMed ID: 24416340
[TBL] [Abstract][Full Text] [Related]
4. Activation of Wnt5A signaling is required for CXC chemokine ligand 12-mediated T-cell migration.
Ghosh MC; Collins GD; Vandanmagsar B; Patel K; Brill M; Carter A; Lustig A; Becker KG; Wood WW; Emeche CD; French AD; O'Connell MP; Xu M; Weeraratna AT; Taub DD
Blood; 2009 Aug; 114(7):1366-73. PubMed ID: 19520808
[TBL] [Abstract][Full Text] [Related]
5. Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects.
Schulte DM; Müller N; Neumann K; Oberhäuser F; Faust M; Güdelhöfer H; Brandt B; Krone W; Laudes M
PLoS One; 2012; 7(2):e32437. PubMed ID: 22384249
[TBL] [Abstract][Full Text] [Related]
6. Secreted frizzled-related protein 5 (SFRP5) protects ATDC5 cells against LPS-induced inflammation and apoptosis via inhibiting Wnt5a/JNK pathway.
Sun M; Wang W; Min L; Chen C; Li Q; Weng W
J Orthop Surg Res; 2021 Feb; 16(1):129. PubMed ID: 33573682
[TBL] [Abstract][Full Text] [Related]
7. Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells.
Yamamoto H; Kitadai Y; Yamamoto H; Oue N; Ohdan H; Yasui W; Kikuchi A
Gastroenterology; 2009 Jul; 137(1):242-52, 252.e1-6. PubMed ID: 19582886
[TBL] [Abstract][Full Text] [Related]
8. Wnt5a activates THP-1 monocytic cells via a β-catenin-independent pathway involving JNK and NF-κB activation.
Kim J; Chang W; Jung Y; Song K; Lee I
Cytokine; 2012 Oct; 60(1):242-8. PubMed ID: 22763043
[TBL] [Abstract][Full Text] [Related]
9. Activation of noncanonical Wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation.
Catalán V; Gómez-Ambrosi J; Rodríguez A; Pérez-Hernández AI; Gurbindo J; Ramírez B; Méndez-Giménez L; Rotellar F; Valentí V; Moncada R; Martí P; Sola I; Silva C; Salvador J; Frühbeck G
J Clin Endocrinol Metab; 2014 Aug; 99(8):E1407-17. PubMed ID: 24840810
[TBL] [Abstract][Full Text] [Related]
10. Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.
Trifa F; Karray-Chouayekh S; Jmal E; Jmaa ZB; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
Tumour Biol; 2013 Jun; 34(3):1625-33. PubMed ID: 23417837
[TBL] [Abstract][Full Text] [Related]
11. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
Jin F; Qu X; Fan Q; Wang L; Tang T; Hao Y; Dai K
Mol Med Rep; 2013 Nov; 8(5):1486-92. PubMed ID: 24064566
[TBL] [Abstract][Full Text] [Related]
12. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q
Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606
[TBL] [Abstract][Full Text] [Related]
13. SFRP5 mediates downregulation of the wnt5a/caveolin-1/JNK signaling pathway.
Liu W; Ji Y; Chu H; Wang M; Yang B; Yin C
J Endocrinol; 2020 Dec; 247(3):263-272. PubMed ID: 33108333
[TBL] [Abstract][Full Text] [Related]
14. Methylation of SFRP5 is related to multidrug resistance in leukemia cells.
Wang H; Wang X; Hu R; Yang W; Liao A; Zhao C; Zhang J; Liu Z
Cancer Gene Ther; 2014 Feb; 21(2):83-9. PubMed ID: 24434572
[TBL] [Abstract][Full Text] [Related]
15. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
Prgomet Z; Axelsson L; Lindberg P; Andersson T
J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer.
Zhao C; Bu X; Zhang N; Wang W
BMC Cancer; 2009 Jul; 9():224. PubMed ID: 19586554
[TBL] [Abstract][Full Text] [Related]
17. Wnt5a involved in regulation of the biological behavior of hepatocellular carcinoma.
Bi L; Liu X; Wang C; Cao Y; Mao R; Li P; Geng M
Int J Clin Exp Pathol; 2014; 7(3):987-95. PubMed ID: 24696716
[TBL] [Abstract][Full Text] [Related]
18. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
[TBL] [Abstract][Full Text] [Related]
19. Balanced duo of anti-inflammatory SFRP5 and proinflammatory WNT5A in children.
Prats-Puig A; Soriano-Rodríguez P; Carreras-Badosa G; Riera-Pérez E; Ros-Miquel M; Gomila-Borja A; de Zegher F; Ibáñez L; Bassols J; López-Bermejo A
Pediatr Res; 2014 Jun; 75(6):793-7. PubMed ID: 24603290
[TBL] [Abstract][Full Text] [Related]
20. Wnt5a induces endothelial inflammation via beta-catenin-independent signaling.
Kim J; Kim J; Kim DW; Ha Y; Ihm MH; Kim H; Song K; Lee I
J Immunol; 2010 Jul; 185(2):1274-82. PubMed ID: 20554957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
